News | August 05, 2021
Alembic gets USFDA nod for Clomipramine Hydrochloride
It had an estimated market size of US $ 32 million as of June 2021
It had an estimated market size of US $ 32 million as of June 2021
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Arch Pharma Labs has filed the application
It is part of the company’s pain/analgesics portfolio of OTC products
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms
Complementary business models are the reason for the acquisition
The govt has rolled out three schemes for promoting the manufacture of API
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Subscribe To Our Newsletter & Stay Updated
